VVV-33444-54227
4 vaccinations
4 coded responses
44 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 662 / KS
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
GS2-12324-39852
Child or adolescent in my care · Male · 2022-06-24
FT5-73862-28703
Child or adolescent in my care · Female · 2022-06-24
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Breast feeding, Dizziness, Loss of personal independence in daily activities — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Felt dizzy and was unable to complete breast milk pumping session had to lay downMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Fair · Site: Pain · ChillsFree text: Pain in axilla of injection site armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Good · Site: Pain · HeadacheFree text: Pain in axilla of injection site armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-19
- 2021-02-24
- 2021-04-14
- 2021-07-14
-
2021-09-28
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Headache, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-19
- 2021-10-27
- 2021-11-02
- 2021-11-09
- 2021-12-28
- 2022-03-29
-
2022-07-30
Dose 4 — Moderna
-
2022-08-01
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessFree text: Lymph node swelling Supra scapular and axillaryMedDRA releases: 2024-11 · check-in free text available
-
2022-08-03
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Headache, Nausea, Vomiting · Be unable to work or attend schoolAdult check-in
-
2022-08-06
Health check-in — day 7, dose 4Feeling: Fair · Headache · Be unable to work or attend schoolAdult check-in
- 2022-08-13
- 2022-08-20
- 2022-08-27
- 2022-09-04
- 2022-09-10
- 2022-10-29
- 2023-01-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
| 4 | 2022-07-30 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-14 | priority 2/3 |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Felt dizzy and was unable to complete breast milk pumping session had to lay down
Systemic reaction (other): Pain in axilla of injection site arm
Systemic reaction (other): Pain in axilla of injection site arm
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Lymph node swelling Supra scapular and axillary
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Breast feeding | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Loss of personal independence in daily activities | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release